Effective February 28, 2024, Ascendis Pharma A/S appointed Mads Bodenhoff as Senior Vice President, Finance Principal Accounting Officer of the Company. Mr. Bodenhoff served as Senior Vice President and Head of Finance of the Company, from June 2021 to March 2024. From March 2018 to June 2021, Mr. Bodenhoff served as Chief Financial Officer at NKT Photonics A/S. From September 2014 to February 2018, Mr. Bodenhoff served as Chief Financial Officer at Xellia Pharmaceuticals, a subsidiary of Novo Holdings A/S. From 2007 to 2014, Mr. Bodenhoff served as Vice President Finance and Vice President Corporate Finance at Novozymes, a global biotechnology company.

Prior to this, Mr. Bodenhoff held leading financial roles for Novozymes within China, Asia Pacific and Latin and North America. Mr. Bodenhoff received a Bachelor in Economics from Handelsh jskolen i Slagelse and a Master Degree in Business Economics and Auditing from Copenhagen Business School. Mr. Bodenhoff is educated as a state authorized public accountant in Denmark.